Legal Opinion

Heron Therapeutics, Inc. v. Fresenius Kabi USA, LLC

District Court, D. Delaware

Decided May 15, 2024No. 1:22-cv-00985Unknown

1Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE HERON THERAPEUTICS, INC., § § Plaintiff, § § v. § FILED UNDER SEAL § FRESENIUS KABI USA, LLC, § Civil Action No. 22-985-WCB § Defendant. § § MEMORANDUM OPINION AND ORDER This is a Hatch-Waxman Act patent case involving U.S. Patent Nos. 9,561,229 (“the ’229 patent”) and 9,974,794 (“the ’794 patent”). Plaintiff Heron Therapeutics, Inc. is the owner of both patents. Heron moves for summary judgment on two discrete issues. Dkt. No. 109. Defendant, Fresenius Kabi USA, LLC moves under Daubert v. Merrell Dow Pharms., Inc.,

509 U.S. 579

(1…

2Cases cited26 opinions

Anderson v. Liberty Lobby, Inc.Supreme Court of the United States · 1986
Celotex Corp. v. Catrett, Administratrix of the Estate of CatrettSupreme Court of the United States · 1986
Daubert v. Merrell Dow Pharmaceuticals, Inc.Supreme Court of the United States · 1993
Kumho Tire Co. v. CarmichaelSupreme Court of the United States · 1999
Nautilus, Inc. v. Biosig Instruments, Inc.Supreme Court of the United States · 2014

21 more not listed; retrieve them via the Exa API.